Financial Performance - The company reported a basic earnings per share of 0.4400 yuan for 2024, a significant increase of 126.19% compared to -1.6800 yuan in 2023 [1] - Net profit for 2024 was 0.29 billion yuan, marking a 126.85% improvement from a net loss of -1.08 billion yuan in 2023 [1] - Operating revenue increased by 37.84% to 4.59 billion yuan in 2024, up from 3.33 billion yuan in 2023 [1] - The return on equity (ROE) improved to 3.80% in 2024 from -13.66% in 2023, reflecting a 127.82% change [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 769.84 million shares, accounting for 34.2% of the circulating shares, with an increase of 62.24 million shares compared to the previous period [2] - Notable new entrants among the top shareholders include Yang Song, Guan Zhuyue, Yang Xingli, Yang Xingwu, and Fu Yong, while Wang Ailing, UBS AG, Mei Weiping, Yu Enyang, and He Linping exited the top ten list [3] Dividend Distribution - The company has proposed a dividend distribution plan of 10 shares for every 4 shares held [5]

Financial Data and Indicators - The basic earnings per share for Q1 2025 remained unchanged at 0.1800 CNY compared to Q1 2024, while it decreased from 0.1900 CNY in Q1 2023 [1] - The net asset per share increased by 8.4% to 8 CNY in Q1 2025 from 7.38 CNY in Q1 2024 [1] - The operating revenue for Q1 2025 was 10.62 billion CNY, a decrease of 2.66% from 10.91 billion CNY in Q1 2024, but an increase from 8.88 billion CNY in Q1 2023 [1] - The net profit for Q1 2025 was 2 billion CNY, unchanged from Q1 2024, but down from 2.11 billion CNY in Q1 2023 [1] - The return on equity (ROE) decreased by 8.1% to 2.27% in Q1 2025 from 2.47% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 76,343.2 million shares, accounting for 68.49% of the circulating shares, with a decrease of 456.69 million shares compared to the previous period [1] - The largest shareholder, Xinlitai Pharmaceutical Co., Ltd., holds 63,527.94 million shares, representing 57.00% of the total share capital, with no change [2] - The second largest shareholder, Shenzhen Xinlitai Pharmaceutical Co., Ltd. - Third Employee Stock Ownership Plan, holds 2,345.75 million shares, accounting for 2.10%, with no change [2] Dividend Distribution - The company has decided not to distribute dividends or transfer shares in this period [2]

数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 4407.65万股，累计占流通股比： 23.11%，较上期变化： -440.16万股。 一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.1000 | 0.3600 | -72.22 | 0.2600 | | 每股净资产（元） | 4.24 | 4.26 | -0.47 | 3.7 | | 每股公积金(元) | 0.71 | 0.71 | 0 | 0.33 | | 每股未分配利润(元) | 2.25 | 2.27 | -0.88 | 2.12 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 20.01 | 17.76 | 12.67 | 18.32 | | 净利润(亿元) | 0.22 | 0.85 | -74.12 | 0.61 | | 净资产收益率(%) | 1.92 | 8.63 | - ...

Financial Performance - The company reported a basic earnings per share of -0.9843 yuan for 2024, a decrease of 421.35% compared to -0.1888 yuan in 2023 [1] - The net profit for 2024 was -4.6 billion yuan, a significant decline of 505.26% from -0.76 billion yuan in 2023 [1] - The return on equity for 2024 was -132.30%, down from -27.37% in 2023, indicating a substantial deterioration in profitability [1] - Total revenue for 2024 was 15.1 billion yuan, a decrease of 7.13% from 16.26 billion yuan in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 10,863.62 million shares, accounting for 33.68% of the circulating shares, which is a decrease of 2,224.96 million shares from the previous period [2] - Guangdong Xingye Investment Co., Ltd. remains the largest shareholder with 8,012.77 million shares, unchanged from the previous report [3] - Notable changes include a decrease in holdings by Chen Huiyin (-240.51 million shares) and Wu Maojiang (-1,322.98 million shares), while new entrants include Chen Xiru and Zhu Jiajia [3] Dividend Policy - The company has announced no distribution or capital increase for the current period [2]

前十大流通股东累计持有： 29410.3万股，累计占流通股比： 35.66%，较上期变化： -624.68万股。 | 名称 | 持有数量(万股) | 占总股本比例(%) | 增减情况(万股) | | --- | --- | --- | --- | | 洛阳古都资产管理有限公司 | 21779.57 | 26.41 | 不变 | | 徐海江 | 2535.88 | 3.07 | 不变 | | 郭长兴 | 2494.82 | 3.03 | -30.00 | | 吴冰 | 638.55 | 0.77 | -235.92 | | 王静波 | 429.88 | 0.52 | -4.00 | | 香港中央结算有限公司 | 387.79 | 0.47 | -411.46 | | 付君惠 | 313.00 | 0.38 | 不变 | | 张金城 | 302.28 | 0.37 | 新进 | | 王博 | 267.70 | 0.32 | 不变 | | 俞智超 | 260.83 | 0.32 | 不变 | | | 较上个报告期退出前十大股东有 | | | | 林镥海 | 245.58 | 0.30 | 退出 | 三、分红送配方案 ...

前十大流通股东累计持有： 55876.87万股，累计占流通股比： 53.14%，较上期变化： 96.77 万股。 | 名称 | 持有数量(万股) | 占总股本比例(%) | 增减情况(万股) | | --- | --- | --- | --- | | 无锡朴华股权投资合伙企业(有限合伙) | 12640.27 | 12.02 | 不变 | | 上海云鑫创业投资有限公司 | 11609.98 | 11.04 | 不变 | | Yue Qi Capital Limited | 7181.15 | 6.83 | -308.51 | | 上海云钜创业投资有限公司 | 6349.21 | 6.04 | 不变 | | 无锡群英股权投资合伙企业(有限合伙) | 3824.54 | 3.64 | 不变 | | 无锡杰华投资合伙企业(有限合伙) | 3079.61 | 2.93 | 不变 | | 香港中央结算有限公司 | 2902.60 | 2.76 | 405.28 | | 无锡易朴投资合伙企业(有限合伙) | 2884.55 | 2.74 | 不变 | | 罗惠玲 | 2740.33 | 2.61 | 不变 | | 无锡曦 ...

一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.5100 | -0.4688 | -8.79 | -0.5326 | | 每股净资产（元） | 0 | 0.67 | -100 | 1.14 | | 每股公积金(元) | 0.27 | 0.16 | 68.75 | 0.23 | | 每股未分配利润(元) | -1.05 | -0.56 | -87.5 | -0.09 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 1.83 | 3.52 | -48.01 | 5.77 | | 净利润(亿元) | -2.7 | -2.48 | -8.87 | -2.82 | | 净资产收益率(%) | -121.25 | -51.69 | -134.57 | -37.63 | 名称 持有数量(万股) 占总股本比例(%) 增减情况(万股) 刘晓艳 114.36 0.22 退出 不分配不转增 数据四舍五入，查 ...

Financial Performance - The company reported a basic earnings per share of -1.0752 yuan for 2024, a decrease of 383.45% compared to -0.2224 yuan in 2023 [1] - The net profit for 2024 was -1.5 billion yuan, a significant decline from -0.31 billion yuan in 2023, representing a 383.87% decrease [1] - The total revenue for 2024 was 21.51 billion yuan, down 5.2% from 22.69 billion yuan in 2023 [1] - The return on equity for 2024 was -20.80%, a drastic drop from -3.84% in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 1.6885 million shares, accounting for 33.83% of the circulating shares, with a decrease of 123.48 thousand shares compared to the previous period [2] - Shanghai Yuwei Investment Partnership holds 473.55 thousand shares, representing 9.49% of the total share capital, with no change [3] - Shenzhen Maoyuan Investment Co., Ltd. decreased its holdings by 3.87 thousand shares, now holding 202.24 thousand shares, which is 4.05% of the total [3] Dividend Policy - The company has decided not to distribute dividends or increase capital [3]

Financial Performance - The company's basic earnings per share decreased by 51.63% to 0.89 yuan in 2024 from 1.84 yuan in 2023 [1] - Net profit fell by 49.12% to 0.58 billion yuan in 2024 compared to 1.14 billion yuan in 2023 [1] - Operating revenue dropped by 34.97% to 2.51 billion yuan in 2024 from 3.86 billion yuan in 2023 [1] - Return on equity decreased by 53.51% to 4.04% in 2024 from 8.69% in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 704.33 million shares, accounting for 33.49% of the circulating shares, with an increase of 96.77 million shares compared to the previous period [1] - New entrants among the top shareholders include Xian Qunkai with 100.48 million shares (4.78%) and Jian Yiting with 36.04 million shares (1.71%) [2] - Notable exits from the top shareholders include Chen Luodan, who held 36.66 million shares (1.74%) [2] Dividend Distribution - The company announced a dividend distribution of 12.22 yuan per share (including tax) [3]

Financial Performance - The company reported a basic earnings per share of -0.7400 yuan for 2024, a significant decrease of 840% compared to 0.1000 yuan in 2023 [1] - The net profit for 2024 was -0.5 billion yuan, representing a drastic decline of 933.33% from 0.06 billion yuan in 2023 [1] - Operating revenue fell to 2.24 billion yuan in 2024, down 45.37% from 4.1 billion yuan in 2023 [1] - The return on equity (ROE) was -6.28% in 2024, a sharp decline of 915.58% from 0.77% in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 8.3148 million shares, accounting for 19.08% of the circulating shares, a decrease of 266.88 thousand shares from the previous period [1] - Notable changes among the top shareholders include a new entry by Tang Xudong with 0.82% ownership and significant exits including Xu Yiyun who held 2.49% [2] Dividend Policy - The company has announced no distribution or capital increase for the current period [3]